A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses

Proceedings of the National Academy of Sciences of the United States of America

Volumn 101, Issue 43, 2004, Pages 15440-15445

  Jackson, David C ^a,c   Yuk, Fai Lau ^a   Le, Thuy ^b   Suhrbier, Andreas ^b   Deliyannis, Georgia ^a,c   Cheers, Christina ^a   Smith, Corey ^a   Zeng, Weiguang ^a   Brown, Lorena E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c VacTX Pty Ltd   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; OVALBUMIN; TOLL LIKE RECEPTOR 2; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL INFECTION; CANCER; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG TARGETING; FEMALE; INFLUENZA VIRUS; LISTERIA MONOCYTOGENES; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; CELL LINE; DENDRITIC CELLS; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES, CYTOTOXIC; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTORS; VACCINES, SYNTHETIC;

ANIMALIA; BACTERIA (MICROORGANISMS); INFLUENZA VIRUS; LISTERIA; LISTERIA MONOCYTOGENES;

EID: 7444271904     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0406740101     Document Type: Article

References (42)

1. Bennett, S. R., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. & Heath, W. R. (1998) Nature 393, 478-480.
2. Ridge, J. P., Di Rosa, F. & Matzinger, P. (1998) Nature 393, 474-478.
3. Kaech, S. M. & Ahmed, R. (2003) Science 300, 263-265.
4. Sette, A. & Fikes, J. (2003) Curr. Opin. Immunol. 15, 461-470.
5. Jackson, D. C., Purcell, A. W., Fitzmaurice, C. J., Zeng, W. & Hart, D. N. (2002) Curr. Drug Targets 3, 175-196.
6. Purcell, A. W., Zeng, W., Mifsud, N. A., Ely, L. K., Macdonald, W. A. & Jackson, D. C. (2003) J. Pept. Sci. 9, 255-281.
7. Medzhitov, R. & Janeway, C. A., Jr. (2002) Science 296, 298-300.
8. Janeway, C. A., Jr. (1989) Cold Spring Harbor Symp. Quant. Biol. 54, 1-13.
9. Beg, A. A. (2002) Trends Immunol. 23, 509-512.
10. Marciani, D. J. (2003) Drug Discov. Today 8, 934-943.
11. BenMohamed, L., Wechsler, S. L. & Nesburn, A. B. (2002) Lancet Infect. Dis. 2, 425-431.
12. Takeuchi, O. & Akira, S. (2001) Int. Immunopharmacol. 1, 625-635.
13. Schjetne, K. W., Thompson, K. M., Nilsen, N., Flo, T. H., Fleckenstein, B., Iversen, J. G., Espevik, T. & Bogen, B. (2003) J. Immunol. 171, 32-36.
14. Zeng, W., Ghosh, S., Lau, Y. F., Brown, L. E. & Jackson, D. C. (2002) J. Immunol. 169, 4905-4912.
15. Ghosh, S., Walker, J. & Jackson, D. C. (2001) Immunology 104, 58-66.
16. Jackson, D. C., Drummer, H. E. & Brown, L. E. (1994) Virology 198, 613-623.
17. Muhlradt, P. F., Kiess, M., Meyer, H., Sussmuth, R. & Jung, G. (1997) J. Exp. Med. 185, 1951-1958.
18. Bodmer, H. C., Pemberton, R. M., Rothbard, J. B. & Askonas, B. A. (1988) Cell 52, 253-258.
19. Harty, J. T. & Bevan, M. J. (1992) J. Exp. Med. 175, 1531-1538.
20. Anraku, I., Harvey, T. J., Linedale, R., Gardner, J., Harrich, D., Suhrbier, A. & Khromykh, A. A. (2002) J. Virol. 76, 3791-3799.
21. Nelson, D. J., Mukherjee, S., Bundell, C., Fisher, S., van Hagen, D. & Robinson, B. (2001) J. Immunol. 166, 5557-5566.
22. Bowie, A., Kiss-Toth, E., Symons, J. A., Smith, G. L., Dower, S. K. & O'Neill, L. A. (2000) Proc. Natl. Acad. Sci. USA 97, 10162-10167.
23. Fitzgerald, K. A., Palsson-McDermott, E. M., Bowie, A. G., Jefferies, C. A., Mansell, A. S., Brady, G., Brini, E., Dunne, A., Gray, P., Harte, M. T., et al. (2001) Nature 413, 78-83.
24. Winzler, C., Rovere, P., Rescigno, M., Granucci, F., Penna, G., Adorini, L., Zimmermann, V. S., Davoust, J. & Ricciardi-Castagnoli, P. (1997) J. Exp. Med. 185, 317-328.
25. Deliyannis, G., Jackson, D. C., Ede, N. J., Zeng, W., Hourdakis, I., Sakabetis, E. & Brown, L. E. (2002) J. Virol. 76, 4212-4221.
26. Coles, R. M., Mueller, S. N., Heath, W. R., Carbone, F. R. & Brooks, A. G. (2002) J. Immunol. 168, 834-838.
27. Gilbertson, B., Zhong, J. & Cheers, C. (1999) J. Immunol. 163, 2073-2080.
28. Liu, Z., Simpson, R. J. & Cheers, C. (1992) Infect. Immun. 60, 4402-4406.
29. Ghosh, S. & Jackson, D. C. (1999) Int. Immunol. 11, 1103-1110.
30. Fitzmaurice, C. J., Brown, L. E., Kronin, V. & Jackson, D. C. (2000) Int. Immunol. 12, 527-535.
31. Takeuchi, O., Kawai, T., Muhlradt, P. F., Morr, M., Radolf, J. D., Zychlinsky, A., Takeda, K. & Akira, S. (2001) Int. Immunol. 13, 933-940.
32. Agrawal, S., Agrawal, A., Doughty, B., Gerwitz, A., Blenis, J., Van Dyke, T. & Pulendran, B. (2003) J. Immunol. 171, 4984-4989.
33. Deres, K., Schild, H., Wiesmuller, K. H., Jung, G. & Rammensee, H. G. (1989) Nature 342, 561-564.
34. Reschner, A., Moretta, A., Landmann, R., Heberer, M., Spagnoli, G. C. & Padovan, E. (2003) Eur. J. Immunol. 33, 2044-2052.
35. Simms, M. S., Scholfield, D. P., Jacobs, E., Michaeli, D., Broome, P., Humphreys, J. E. & Bishop, M. C. (2000) Br. J. Cancer 83, 443-446.
36. Anonymous (2003) BioDrugs 17, 223-225.
37. Brett, B. T., Smith, S. C., Bouvier, C. V., Michaeli, D., Hochhauser, D., Davidson, B. R., Kurzawinski, T. R., Watkinson, A. F., Van Someren, N., Pounder, R. E. & Caplin, M. E. (2002) J. Clin. Oncol. 20, 4225-4231.
38. Talwar, G. P. (1999) Immunol. Rev. 171, 173-192.
39. Re, F. & Strominger, J. L. (2001) J. Biol. Chem. 276, 37692-37699.
40. Toshchakov, V., Jones, B. W., Perera, P. Y., Thomas, K., Cody, M. J., Zhang, S., Williams, B. R., Major, J., Hamilton, T. A., Fenton, M. J. & Vogel, S. N. (2002) Nat. Immunol. 3, 392-398.
41. Ito, T., Amakawa, R., Kaisho, T., Hemmi, H., Tajima, K., Uehira, K., Ozaki, Y., Tomizawa, H., Akira, S. & Fukuhara, S. (2002) J. Exp. Med. 195, 1507-1512.
42. Weigt, H., Muhlradt, P. F., Emmendorffer, A., Krug, N. & Braun, A. (2003) Immunobiology 207, 223-233.